Provided by Tiger Trade Technology Pte. Ltd.

Palvella Therapeutics

150.56
-3.7600-2.44%
Post-market: 150.700.1400+0.09%19:30 EDT
Volume:646.46K
Turnover:97.53M
Market Cap:2.17B
PE:-30.74
High:154.72
Open:154.72
Low:149.20
Close:154.32
52wk High:161.38
52wk Low:56.22
Shares:14.41M
Float Shares:8.40M
Volume Ratio:3.36
T/O Rate:7.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8978
EPS(LYR):-3.7076
ROE:-46.63%
ROA:-22.05%
PB:10.00
PE(LYR):-40.61

Loading ...

Nov 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Sep 24, 2025

Major Issues Report

Form 8-K - Current report
Sep 03, 2025

Major Issues Report

Form 8-K - Current report
Aug 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 15, 2025

Correspondence

Form CORRESP - Correspondence
Jan 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 31, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]